Reproductive Justice, Health & Rights

Advocates for reproductive health, rights, and justice are increasingly aware of the safety and social risks of assisted reproductive technologies and other human biotechnologies, particularly for women and children.

While assisted reproduction has helped many people create families, the long-term risks of these technologies – particularly those that require egg provision – are grossly understudied. In the U.S., assisted reproduction has developed almost entirely in the commercial sector and is notoriously underregulated. 

Heritable genome editing, if allowed, would develop in this same commercial sector. Reproductive justice advocates draw attention to the risks to women and children’s health and wellbeing, the historical context of population control and reproductive oppression, and the likelihood that it would exacerbate reproductive, racial, and disability injustice.

Biopolitical Times
New materials from CGS and Black Women for Wellness put the development of germline modification within the context of historical attempts to control the reproductive lives of women, trans, and nonbinary people.
Biopolitical Times
On June 13, the Center for Genetics and Society, alongside Black Women for Wellness and In Our Own Voice National Black Women’s Reproductive Justice Agenda, will be hosting the webinar, “Gene Editing and the Future of Reproductive Justice.”...

Aggregated News

Medical researchers would be allowed to buy women’s eggs under a bill being considered by the Legislature this week. As pro-choice, feminist scholars, we are deeply troubled by this legislation.
Biopolitical Times

Photo from Belly of the Beast, used by permission

Yesterday, California became the third state in the nation to...

Harriet discussed her experiences writing and talking about the increasingly powerful “medical-industrial complex,” the erosion of informed consent in biomedical research, and the ways that commercial dynamics have aggravated issues of distributive and social justice. She also describes the resistance she has encountered when writing about these topics, especially in response to her recently published book Deadly Monopolies: The Shocking Corporate Takeover of Life Itself--And the Consequences for Your Health and Our Medical Future. She addressed opportunities for scholars to engage more directly in communicating their ideas to broader audiences and the difficulties they may face in “going public.” And she pressed the case she makes in Deadly Monopolies for what Osagie Obasogie called, in a review of the book “a broader political consciousness of science and technology.